For instance, it has been shown that myriocin, a potent SPT inhibitor, suppresses murine melanoma growth (Lee et al., 2012) and mediates the regression of atherosclerotic lesions in hyperlipidemic apolipoprotein E knockout mice (Park et al., 2008). The gene discussed is AGXT; the disease is melanoma.